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A B S T R A C T
Background
Asthma remains a significant cause of avoidable morbidity and mortality. Regular check-ups with a healthcare professional are essential
to monitor symptoms and adjust medication.
Health services worldwide are considering telephone and internet technologies as a way to manage the rising number of people with
asthma and other long-term health conditions. This may serve to improve health and reduce the burden on emergency and inpatient
services. Remote check-ups may represent an unobtrusive and efficient way of maintaining contact with patients, but it is uncertain
whether conducting check-ups in this way is effective or whether it may have unexpected negative consequences.
Objectives
To assess the safety and efficacy of conducting asthma check-ups remotely versus usual face-to-face consultations.
Search methods
We identified trials from the Cochrane Airways Review Group Specialised Register (CAGR) up to 24 November 2015. We also searched
www.clinicaltrials.gov, the World Health Organization (WHO) trials portal, reference lists of other reviews and contacted trial authors
for additional information.
Selection criteria
We included parallel randomised controlled trials (RCTs) of adults or children with asthma that compared remote check-ups con-
ducted using any form of technology versus standard face-to-face consultations. We excluded studies that used automated telehealth
interventions that did not include personalised contact with a health professional. We included studies reported as full-text articles, as
abstracts only and unpublished data.
Data collection and analysis
Two review authors screened the literature search results and independently extracted risk of bias and numerical data. We resolved any
disagreements by consensus, and we contacted study authors for missing information.
We analysed dichotomous data as odds ratios (ORs) using study participants as the unit of analysis, and continuous data as mean
differences using the random-effects models. We rated all outcomes using the Grading of Recommendations Assessment, Development
and Evaluation (GRADE) approach.
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Main results
Six studies including a total of 2100 participants met the inclusion criteria: we pooled four studies including 792 people in the main
efficacy analyses, and presented the results of a cluster implementation study (n = 1213) and an oral steroid tapering study (n = 95)
separately. Baseline characteristics relating to asthma severity were variable, but studies generally recruited people with asthma taking
regular medications and excluded those with COPD or severe asthma. One study compared the two types of check-up for oral steroid
tapering in severe refractory asthma and we assessed it as a separate question. The studies could not be blinded and dropout was high
in four of the six studies, which may have biased the results.
We could not say whether more people who had a remote check-up needed oral corticosteroids for an asthma exacerbation than those
who were seen face-to-face because the confidence intervals (CIs) were very wide (OR 1.74, 95% CI 0.41 to 7.44; 278 participants;
one study; low quality evidence). In the face-to-face check-up groups, 21 participants out of 1000 had exacerbations that required
oral steroids over three months, compared to 36 (95% CI nine to 139) out of 1000 for the remote check-up group. Exacerbations
that needed treatment in the Emergency Department (ED), hospital admission or an unscheduled healthcare visit all happened too
infrequently to detect whether remote check-ups are a safe alternative to face-to-face consultations. Serious adverse events were not
reported separately from the exacerbation outcomes.
There was no difference in asthma control measured by the Asthma Control Questionnaire (ACQ) or in quality of life measured on
the Asthma Quality of Life Questionnaire (AQLQ) between remote and face-to-face check-ups. We could rule out significant harm of
remote check-ups for these outcomes but we were less confident because these outcomes are more prone to bias from lack of blinding.
The larger implementation study that compared two general practice populations demonstrated that offering telephone check-ups and
proactively phoning participants increased the number of people with asthma who received a review. However, we do not know whether
the additional participants who had a telephone check-up subsequently benefited in asthma outcomes.
Authors’ conclusions
Current randomised evidence does not demonstrate any important differences between face-to-face and remote asthma check-ups in
terms of exacerbations, asthma control or quality of life. There is insufficient information to rule out differences in efficacy, or to say
whether or not remote asthma check-ups are a safe alternative to being seen face-to-face.
P L A I N L A N G U A G E S U M M A R Y
Are telephone or internet check-ups a safe alternative to being seen face-to-face?
Take-home message
Studies that tried to answer this research question did not show important differences between the two types of check-up. However,
there is not enough information to rule out differences in their harms or benefits. At this stage, we cannot say whether or not asthma
check-ups conducted over the phone or internet are a safe alternative to usual face-to-face consultations.
Background
Regular contact with a doctor or asthma nurse is essential to keep track of symptoms and use of inhalers. Telephone and internet
technologies may be a way to manage the rising number of people with asthma and other long-term health conditions. This has been
referred to as ’remote reviews’ or e-consultations, and may be a way of more easily keeping contact between patients and doctors, but
we don’t know whether it’s as good as meeting face-to-face.
Study characteristics
We found a total of six studies including 2100 participants: four studies including 792 people could be pooled for the main results,
and two other studies were looked at separately because their designs were very different (n = 1213 and n = 95). People in the four
pooled studies in general took regular medications and we excluded those with severe asthma or other lung diseases. We looked at two
other studies with very different designs to the main four separately: one compared a practice where people with asthma were given the
option of a telephone check-up or a practice visit where they came to the clinic as usual, and one looked specifically at using technology
to monitor people while cutting down their oral steroids dose. We last looked for studies on 24 November 2015.
Key results
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We cannot say whether or not people who had a check-up over the phone or internet were more or less likely to need oral corticosteroids
for an asthma attack than those seen face-to-face, and we were uncertain of the result for several reasons. Too few people had asthma
attacks that needed treatment in the Emergency Department or hospital, or an unscheduled visit to see their doctor to tell if remote
check-ups were as good as face-to-face consultations. There didn’t appear to be a difference in asthma control or quality of life, but we
were able to rule out the possibility that remote check-ups are not as good as face-to-face consultations on these measures. The evidence
was all considered to be of low or moderate quality. The study that tested the possible benefit of giving people the option of a telephone
check-up showed that this increased the number of people reviewed, but did not show an overall benefit on asthma outcomes.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Remote versus face- to- face check-ups for asthma
Patient or population: adults or children with asthma
Setting: outpat ient
Intervention: remote check-ups conducted using technology (e.g. telephone, email)
Comparison: f ace-to-face asthma check-ups
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with face- to- face
check-ups
Risk with remote
check-ups
Exacerbat ions requir-
ing oral cort icosteroids
3 months
21 per 1000 36 per 1000
(9 to 139)
OR 1.74
(0.41 to 7.44)
278
(1 RCT)
⊕⊕©©
low1,2
Very imprecise. Data
f rom the implementa-
t ion study* * were con-
sistent
Exacerbat ions requir-
ing hospital admission
6 months
5 per 1000 3 per 1000
(0 to 33)
Peto OR 0.63
(0.06 to 6.32)
651
(3 RCTs)
⊕⊕©©
low1,3
Very few events - no
conclusion could be
drawn. The implemen-
tat ion study was more
in favour of face-to-
face check-ups
Asthma control (ACQ)
Scale 0 to 6; lower is
better
12 months
The mean ACQ
score with face-to-face
check-ups improved by
0.11
The mean ACQ score
with remote check-ups
improved by 0.07 more
(0.35 more to 0.21 less)
- 146
(1 RCT)
⊕⊕⊕©
moderate 4,5
No dif ference and CIs
ruled out signif icant
harm of remote check-
ups (MCID for the ACQ
is 0.5). The imple-
mentat ion study results
were consistent
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Serious adverse events
(including mortality)
- - - 0 RCTs - No ef f icacy stud-
ies reported all-cause
SAEs. The implementa-
t ion study recorded 12/
554 and 8/ 659 in the re-
mote and face-to-face
groups respect ively (OR
1.80, 95% CI 0.73 to 4.
44)
Asthma-related quality
of lif e (AQLQ)
Scale 1 to 7; higher is
better
8 months
The mean AQLQ
score with face-to-face
check-ups was 5.49
The mean AQLQ score
with remote check-ups
was 0.08 better
(0.14 worse to 0.30 bet-
ter)
- 544
(3 RCTs)
⊕⊕⊕©
moderate 4,5
No dif ference and CIs
ruled out signif icant
harm of remote check-
ups (MCID for the AQLQ
is 0.5). The imple-
mentat ion study results
were consistent
Unscheduled health-
care visits
5 months
120 per 1000 110 per 1000
(58 to 201)
OR 0.91
(0.45 to 1.85)
531
(2 RCTs)
⊕⊕©©
low1,3
Very few events - we
could not draw any
conclusions. The imple-
mentat ion study was
more precise and did
not show a dif ference
Lung funct ion (trough
FEV1)
6 months
The mean trough
FEV1 with face-to-face
check-ups was 20 mL
The mean trough FEV1
with remote check-ups
was 166.76 mL better
(78.03 more to 255.5
more)
- 253
(1 RCT)
⊕⊕⊕©
moderate 1,6
People having remote
check-ups had bet-
ter lung funct ion than
those seen face-to-face
in the one study that
measured it
* The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI). The risk
with face-to-face check-ups for cont inuous outcomes was calculated as a weighted mean of the face-to-face values.
Abbreviat ions: CI = conf idence interval; RR = risk rat io; OR = odds rat io; ED = emergency department; ACQ = Asthma Control Quest ionnaire; AQLQ = Asthma Quality of Life
Quest ionnaire; FEV1 = forced expiratory volume in one second; RCT = randomised controlled trial
* * The ’Implementat ion study’, Pinnock 2007a, had a two-cluster pragmatic design and was not pooled with the rest of the included studies (ef f icacy studies)
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Durat ions were calculated as a weighted mean durat ion of the studies contribut ing data to the analysis
GRADE Working Group grades of evidence
High quality: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect.
M oderate quality: we are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent.
Low quality: our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect.
Very low quality: we have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Studies were at high risk of bias for one or more blinding domains but it is unlikely that this had an ef fect on the object ive
outcomes (no downgrade).
2Evidence f rom 1 study with 7 events. There were very wide CIs (downgrade by 2 for imprecision).
3The ef fect was based on very few events. The 95% conf idence intervals included signif icant harm and signif icant benef it of
remote check-ups (downgraded by 2 for imprecision).
4The upper lim it of the CI crossed the line of no ef fect but both lim its were well within the 0.5 unit m inimal clinically important
dif f erence for the scale (no downgrade).
5Studies were at high risk of bias for blinding which may have af fected this subject ive outcome, and there was evidence of
possible attrit ion bias (downgraded by 1 for risk of bias).
6The CIs excluded benef it of face-to-face check-ups but they were wide and based on only one study of 253 people
(downgraded by 1 for imprecision).
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B A C K G R O U N D
Description of the condition
Asthma is a chronic disease of the airways, which causes reversible
inflammation and narrowing of the airways and mucus produc-
tion (GINA 2014). It commonly causes symptoms of wheezing,
breathlessness, chest tightness and cough, although these vary be-
tween people and over time in their presence, frequency and sever-
ity (GINA 2014).
Despite the emergence and update of several national and interna-
tional management guidelines which recommend a range of cost-
effective treatments based on frequency and severity of symptoms
and exacerbations (e.g. BTS/SIGN 2014; GINA 2014), the dis-
ease remains a significant cause of avoidable morbidity and mor-
tality worldwide (BTS/SIGN 2014; Global Asthma Report 2014;
NRAD 2014). A national review of the 195 asthma deaths that
occurred between February 2012 and January 2013 in the UK re-
vealed that, in the year preceding their death, nearly one-third had
no record of seeing a general practitioner (GP) and nearly two-
thirds had not had an asthma check-up in secondary care (NRAD
2014). The importance of self-monitoring and regular check-ups
with a healthcare professional to monitor symptoms, and encour-
age adherence to preventer inhalers, is now well accepted (Gibson
2002; NRAD 2014), especially for people at high risk of severe
asthma attacks.
Description of the intervention
Communication technologies, such as telephones and video con-
ferencing, have been proposed as a way to conduct asthma check-
ups remotely. Conducting check-ups in this way is a form of
’telehealth’, otherwise referred to as ’telecare’, ’digital health’,
’telemedicine’ or ’e-health’. McLean 2013 described this field as
“the use of information and communication technologies to de-
liver healthcare at a distance and to support patient self-manage-
ment through remote monitoring and personalised feedback”. It
may also be conceptualised as “an emerging field in the intersec-
tion of medical informatics, public health and business, referring
to health services and information delivered or enhanced through
the internet and related technologies (Eysenback 2001). Health
services around the world are considering remote check-ups as a
way to manage the rising number of people with long-term health
conditions, to improve health outcomes and reduce the burden on
emergency and inpatient services (Department of Health 2012;
Steventon 2012).
The UK government outlined its aims for the widespread use of
technology in health in their 2013 mandate, including wide avail-
ability of ’e-consultations’ byGPs, and significant progress towards
home ’telemonitoring’ of threemillion people with long-term con-
ditions by 2017 (Department of Health 2013). Researchers have
studied the role of a range of technology-based check-ups and
monitoring in asthma and other health conditions, including the
use of telephone calls, email contact, text-messaging and video-
conferencing (Laver 2013; McLean 2010; McLean 2011).
How the intervention might work
In the context of asthma, a condition that affects around 334 mil-
lion people worldwide (Global Asthma Report 2014) and places a
significant burden on healthcare systems, remote check-ups may
represent an unobtrusive and efficient way of maintaining con-
tact with patients. Regular monitoring with communication tech-
nologies that does not disrupt a patient’s life in the way that reg-
ular clinic visits might, may serve to enhance self management
behaviours that have known benefits on morbidity and mortality,
such as keeping personalised action plans up-to-date, and adher-
ence to maintenance medications (NRAD 2014).
However, while governments and health services have highlighted
the potential for cost savings and improved clinical outcomes of
using remote check-ups instead of face-to-face consultations, its
use to monitor patients with potentially serious or life-threatening
conditions may not be without hazard. Focus groups have sug-
gested that telehealthmay be acceptable to patients and clinicians,
but they have also raised concerns that it could actually discourage
self management, or increase the likelihood of serious outcomes,
by instilling a false sense of security (Pinnock 2007b).
The feasibility of using communication technologies in different
situations andpopulationsmay be hampered by barriers, including
insufficient healthcare infrastructure and funding (Lustig 2012).
However, itmay be away to reduce inequality in health care related
to socioeconomic status and rural living by improving access to
services (Jannett 2003; Lustig 2012).
Why it is important to do this review
The release of the UKNational Health Service (NHS) mandate in
2013 has seen a push to advance the use of telehealth for economic
and clinical benefit. A recent overview of systematic reviews sug-
gested that these benefits should not be assumed and that people
at highest risk of serious health outcomes are likely to show the
biggest gains (McLean 2013). For asthma, existing reviews have
noted a large degree of variation in theway telehealth is defined and
delivered in studies, to whom and to what it is compared (Jaana
2009; McLean 2010), and have been limited for this reason in the
conclusions that could be drawn. This Cochrane review will focus
on conducting asthma check-ups remotely as a form of telehealth
compared with usual face-to-face consultations in a hospital or
clinic. A related Cochrane review will consider the evidence for
remote monitoring of asthma control between visits with ongoing
personalised feedback from a health professional (Kew 2015a).
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O B J E C T I V E S
To assess the safety and efficacy of conducting asthma check-ups
remotely versus usual face-to-face consultations.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel randomised controlled trials (RCTs) of any
duration. We included studies reported as full-text articles, those
published as an abstract only and unpublished data.
Types of participants
We included studies of adults or children with a diagnosis of
asthma.We excluded studies that recruited participants with other
long-term health conditions, unless they presented data for people
with asthma separately.
Types of interventions
We included trials that compared remote check-ups conducted
with any form of technology (e.g. telephone calls, video-confer-
encing) versus standard face-to-face check-ups. We included trials
which compared the two types of check-up on top of education or
another co-intervention. We excluded trials that used automated
telehealth interventions and did not include personalised contact
with a health professional.
Types of outcome measures
Primary outcomes
1. Exacerbations that required oral corticosteroidsa .
2. Asthma control (measured on a validated scale, e.g. the
Asthma Control Questionnaire (ACQ)).
3. Serious adverse events (including mortality).
aIf trials reported exacerbations in a different way (e.g. required
hospital emergency department (ED) visit), we analysed these sep-
arately.
Secondary outcomes
1. Asthma-related quality of life (measured on a validated
scale, e.g. the Asthma Quality of Life Questionnaire (AQLQ)).
2. Unscheduled healthcare visits.
3. Lung function (trough forced expiratory volume in one
second (FEV1) preferred).
4. Adverse events/side effects.
Reporting of one or more of the outcomes listed here in the trial
was not an inclusion criterion for this Cochrane review.
Search methods for identification of studies
Electronic searches
We identified trials from the Cochrane Airways Review Group’s
Specialised Register (CAGR), which is maintained by the Infor-
mation Specialist for the Cochrane Airways Review Group. The
CAGRcontains trial reports identified through systematic searches
of bibliographic databases including the Cochrane Central Reg-
ister of Controlled Trials (CENTRAL), MEDLINE, EMBASE,
CINAHL, AMED, and PsycINFO, and handsearches of respira-
tory journals and meeting abstracts (please see Appendix 1 for fur-
ther details). We used the search strategy in Appendix 2 to search
for all records in the CAGR.
We also
conducted a search of ClinicalTrials.gov (www.ClinicalTrials.gov)
and the World Health Organization (WHO) International Clini-
cal Trials Registry Portal (www.who.int/ictrp/en/) limited to inter-
ventional studies, using the condition term ’asthma’, intervention
terms ’remote OR telehealth OR telemedicine OR internet OR
web’, and title terms ’NOT education’. We searched all databases
from their inception to 24 November 2015, and did not impose
any restriction on language of publication.
Searching other resources
We checked reference lists of all primary studies and review articles
for additional references.
We searched for errata or retractions from included studies pub-
lished in full-text on PubMed (www.ncbi.nlm.nih.gov/pubmed)
on 20 July 2015.
Data collection and analysis
Selection of studies
Two review authors (KK and CJC) independently screened titles
and abstracts for inclusion of all the potential studies identified
from the literature searches and coded them as either ’retrieve’
(eligible or potentially eligible/unclear) or ’do not retrieve’. We
retrieved the full-text study reports/publication and two review
authors (KK and CJC) independently screened the full-text and
identified studies for inclusion, and identified and recorded rea-
sons for exclusion of the ineligible studies. We resolved any dis-
agreement through discussion. We identified and excluded dupli-
cates and collated multiple reports of the same study so that each
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study, rather than each report, was the unit of interest in the review.
We recorded the selection process in sufficient detail to complete
a PRISMA flow diagram and ’Characteristics of excluded studies’
table (Moher 2009).
Data extraction and management
We used a data collection form for study characteristics and out-
come data, which we piloted on at least one study included in
the review. One review author (KK) extracted the following study
characteristics from included studies.
1. Methods: study design, total duration of study, details of
any ’run in’ period, number of study centres and location, study
setting, withdrawals and date of study.
2. Participants: number of participants, mean age, age range,
gender, severity of condition, diagnostic criteria, baseline lung
function, smoking history, inclusion criteria and exclusion
criteria.
3. Interventions: intervention, comparison, concomitant
medications and excluded medications.
4. Outcomes: primary and secondary outcomes specified and
collected, and time points reported.
5. Notes: trial funding and notable conflicts of interest of the
trial authors.
Two review authors (KK and CJC) independently extracted
outcome data from the included studies. We noted in the
’Characteristics of included studies’ table if the study authors did
not report outcome data in a usable way.We resolved any disagree-
ments by consensus. One review author (KK) transferred data into
the Review Manager (RevMan) (RevMan 2014) file. We double-
checked that KK entered data correctly by comparing the data
presented in the systematic review with the study reports. A sec-
ond review author (CJC) spot-checked study characteristics for
accuracy against the trial report.
Assessment of risk of bias in included studies
Two review authors (KK and CJC) independently assessed the risk
of bias for each included study using the criteria outlined in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011). We resolved any disagreements by discussion. We assessed
the risk of bias according to the following domains.
1. Random sequence generation.
2. Allocation concealment.
3. Blinding of participants and personnel.
4. Blinding of outcome assessment.
5. Incomplete outcome data.
6. Selective outcome reporting.
7. Other bias.
We graded each potential source of bias as either ’high’, ’low’ or
’unclear’, and provided a quote from the study report together
with a justification for our judgment in the ’Risk of bias’ table.We
summarised the ’Risk of bias’ judgements across different studies
for each domain listed. We considered blinding separately for dif-
ferent key outcomes where necessary (e.g. for unblinded outcome
assessment, risk of bias for all-cause mortality may be very differ-
ent than for a patient-reported pain scale). Where information on
risk of bias related to unpublished data or correspondence with a
trial author, we noted this in the ’Risk of bias’ table.
When we considered treatment effects, we took into account the
risk of bias for the studies that contributed to that outcome.
Assessment of risk of bias in conducting the
systematic review
We conducted the review according to the published Cochrane
protocol, Kew 2015b, and reported any deviations from it in the
’Differences between protocol and review’ section.
Measures of treatment effect
We analysed dichotomous data as odds ratios (ORs) and contin-
uous data as either mean difference or standardised mean differ-
ence values. We entered data presented as a scale with a consistent
direction of effect.
We undertook meta-analyses only where this was meaningful, i.e.
if the treatments, participants and the underlying clinical question
were similar enough for pooling to make sense.
We narratively described skewed data reported as medians and
interquartile ranges.
Where a single trial reported multiple trial arms, we only included
the relevant trial arms. If the trial combined two comparisons (e.g.
drugA versus placebo anddrugBversus placebo) in the samemeta-
analysis, we halved the control group to avoid double-counting.
Unit of analysis issues
For dichotomous outcomes we used participants, rather than
events, as the unit of analysis (i.e. number of adults admitted to
hospital, rather than number of admissions per adult). However,
if studies reported exacerbations as rate ratios, we analysed them
on this basis. We did not anticipate the inclusion of cluster RCTs
and hence presented a large two-cluster implementation study,
Pinnock 2007a, separately from the other studies. For the purposes
of display in the analyses, we have referred to Pinnock 2007a as the
’cluster implementation study’ and Chan 2007, Gruffydd-Jones
2005, Pinnock 2003 and Rasmussen 2005 as the ’efficacy RCTs’.
There were only two clusters so we included the data with partici-
pants as the unit of analysis. Although we presented the results of
the cluster RCT on forest plots with the other studies, we did not
pool the effects so weighting of the cluster trial within the analy-
sis was not an issue. We presented Hashimoto 2011 in a separate
comparison as the study focused on tapering OCS dose.
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Dealing with missing data
We contacted the study authors or study sponsors in order to verify
key study characteristics and obtain missing numerical outcome
data where possible (e.g. when we identified a study as an abstract
only). Where this was not possible, and we thought the missing
data introduced serious bias, we explored the impact of including
such studies in the overall assessment of results by a sensitivity
analysis.
Assessment of heterogeneity
We used the I² statistic to measure heterogeneity among the tri-
als in each analysis. If we identified substantial heterogeneity we
reported it and explored possible causes by prespecified subgroup
analysis.
Assessment of reporting biases
If we were able to pool more than 10 trials, we created and examine
a funnel plot to explore possible small study and publication biases.
Data synthesis
We used a random-effects model for all analyses, as we expected
variation in effects due to differences in study populations and
interventions.We performed sensitivity analyses with a fixed-effect
model when heterogeneity was statistically significant.
’Summary of findings’ table
We created a ’Summary of findings’ table using the seven outcomes
listed above. We used the five GRADE considerations (study lim-
itations, consistency of effect, imprecision, indirectness and pub-
lication bias) to assess the quality of a body of evidence as it relates
to the studies which contribute data to the meta-analyses for the
prespecified outcomes. We used methods and recommendations
described in Section 8.5 and Chapter 12 of the Cochrane Hand-
book for Systematic Reviews of Interventions, Higgins 2011, and
used GRADEpro Guidelines Development Tool (GDT) software
(GRADEproGDT 2015).We justified all decisions to downgrade
or upgrade the quality of the evidence in footnotes, and we made
comments to aid the reader’s understanding of the Cochrane re-
view, where necessary.
Subgroup analysis and investigation of heterogeneity
We performed the following subgroup analyses for the primary
outcomes, where there was a sufficient number of included studies.
1. Mean age (less than 16 years, 17 to 65 years, and greater
than 65 years).
2. Type of technology (telephone calls, text-messages, emails).
We used the formal test for subgroup interactions in ReviewMan-
ager (RevMan) (RevMan 2014).
Sensitivity analysis
We carried out the following sensitivity analyses by exclusion of
the following from the primary analyses.
1. Studies that recruited people with severe or life-threatening
asthma.
2. Unpublished data (obtained from trial authors or from
conference abstracts).
3. Studies at high risk of selection biasa .
aInadequate selection procedures may result in unbalanced base-
line characteristics between groups which could skew the data.
Due to the nature of the studies, we anticipated that all or most
included studies would be at high risk of performance or detec-
tion bias, so we discussed the possible effect of lack of blinding, in
particular for subjective outcomes.
R E S U L T S
Description of studies
Results of the search
We performed searches up to 24 November 2015. We identi-
fied 591 records from the Cochrane Airways Review Group’s Spe-
cialised Register (CAGR). We also examined a total of 750 addi-
tional records, comprised of an older database search (n = 710),
clinicaltrials.gov records (n = 29) and the World Health Organi-
zation (WHO) International Clinical Trials Registry Portal (IC-
TRP) (n = 11). After we removed duplicates, we screened the re-
maining 823 records and excluded 673 by looking at titles and ab-
stracts alone. We retrieved full texts for the remaining 150 records
and excluded 126 (collated into 95 studies). The other 25 records
met all the inclusion criteria and we collated them as six included
studies. We have presented a study flow diagram and the reasons
for exclusion in Figure 1.
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Figure 1. Study flow diagram
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Included studies
Six studies including a total of 2100 participants met the inclusion
criteria: we pooled four studies including 792 people in the main
efficacy analyses, and presented the results of a cluster implemen-
tation study (n = 1213) and an oral steroid tapering study (n = 95)
separately.We have presented a summary of study, participant and
intervention characteristics in Table 1, and more details for each
individual study are in the ’Characteristics of included studies’ ta-
bles.
Design, setting and duration
Three included studieswere conducted in theUK (Gruffydd-Jones
2005; Pinnock 2003; Pinnock 2007a), one inHawaii, USA (Chan
2007), one in theNetherlands (Hashimoto 2011) and one inDen-
mark (Rasmussen 2005). Five studies were randomised controlled
trials (RCTs) that lasted six or 12 months, and Pinnock 2007a was
a before-and-after implementation study which randomised three
practices rather than individual participants.
The design of Pinnock 2007a differed from the other studies in
several respects. Firstly, it was cluster randomised which had an ef-
fect on the unit used for analysis and could not completely control
for potential group differences between the practices. Secondly, it
was a before-and-after design which meant the number and type
of people on the practice lists was different at the two time points.
Thirdly, the intervention offered a telephone check-up as an op-
tion for asthma review so the study did not make a clean compar-
ison between remote and face-to-face check-ups, especially since
most people in the telephone group did not choose that option.
Fourthly, the primary aim of the study was to increase the number
of people having a check-up at all and so people in the intervention
group were phoned opportunistically on top of being offered a
phone check-up, and this additional effort to contact participants
may have been a confounding factor on the other study outcomes.
We considered the study to be important so did not exclude it,
and instead presented the study results separately from the main
comparison for each outcome.
Population characteristics and inclusion criteria
The number of participants in each trial ranged from 95 in
Hashimoto 2011 to 1728 in Pinnock 2007a; the median number
of participants recruited was 236 and the total who received phone
or face-to-face check-ups was 2100. This was complicated by the
design of Pinnock 2007a which assigned three GP practices rather
than individual participants, although we will discuss the num-
ber of people for the descriptive purposes. Five studies recruited
adults with a lower age limit of 17 or 18 and an upper age lim-
its of between 45 (Rasmussen 2005) and 75 (Hashimoto 2011).
Mean age of participants in the adult trials ranged from 29 to 55.5
years (median 50.1). One study recruited children between the
ages of six and 17 years, and had a mean age of 9.6 years (Chan
2007). Studies included slightly more females than males (range
34.5% to 62.5% male, median 45%). Baseline characteristics re-
lated to the asthma severity were patchy and variable across studies.
Hashimoto 2011 recruited people with more severe asthma than
the other included studies; the mean percentage predicted FEV1
at baseline was 73.9%. Two other studies reported this measure
of baseline severity at 92% (Rasmussen 2005) and 100.5% (Chan
2007).
In general the included studies did not describe the inclusion and
exclusion criteria in great detail, and had varying requirements
for the diagnosis and classification of asthma in their participants.
With the exception ofHashimoto 2011, the studies recruited from
the practice or clinic lists of their participating centres. Pinnock
2003 and Pinnock 2007a required participants to have received a
prescription for asthmamedicationswithin the previous six and 12
months respectively, and both excluded participants with chronic
obstructive disease. Pinnock 2003 further required participants to
have been diagnosed with asthma for at least a year. Other inclu-
sion criteria were related to computer or telephone access, and ex-
clusion criteria were related to social, communication or medical
difficulties that might preclude involvement in the intervention.
Hashimoto 2011 only recruited participants on daily oral corti-
costeroids, and its inclusion criteria differed from the other stud-
ies. This study required participants to have a diagnosis of severe
refractory asthma according to the major and minor criteria rec-
ommended by the American Thoracic Society (ATS 2000), and
for their asthma to be uncontrolled despite intensive follow-up by
an asthma specialist for at least a year, chronic treatment with oral
corticosteroids and high doses of inhaled steroids and long-acting
bronchodilators.
Interventions and comparisons
The interventions received in the active and comparison groups
varied in several respects across studies, in particular regarding the
length of observation, amount of professional contact andmethod
of communication.
Four studies were designed to test remote check-ups with stan-
dard face-to-face care. Chan 2007 was the only child study, and
tested an in-home website case management and education pro-
gramme against an in-person equivalent for 12 months. Partici-
pants in the active group of Gruffydd-Jones 2005 received phone
calls every six months from trained asthma nurses and those in
the intervention group had equivalent face-to-face check-ups with
the asthma nurse. Both groups were given a personalised asthma
action plan and discussed symptoms, peak flow and inhaler tech-
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nique. Pinnock 2003 was described as a pragmatic RCT where
participants were offered a telephone check-up or a face-to-face
consultation in the surgery, both with an asthma nurse. One of the
study’s main aims was the uptake of check-ups with either method
within three months of randomisation. Rasmussen 2005 was a six-
month study where physicians gave participants instructions via
email or over the phone based on an agreed asthma action plan,
an online diary and peak flow measurements uploaded by the par-
ticipant. The comparison group received face-to-face instruction
from an asthma specialist on how to adjust medication based on
their asthma action plan and peak flow measurements.
As described above, Pinnock 2007a was a 12-month implementa-
tion study where participants were given a structured recall with a
choice of telephone or face-to-face for their asthma check-up or a
structured recall with no choice of a telephone check-up (i.e. face-
to-face only). We did not include a usual-care group not subject
to the methods to control for bias in the main comparison in this
review. We chose to present the results of this study alongside the
results of the four studies above, but in a separate subgroup so we
did not pool the data with themain comparison. In addition to the
choice of a telephone check-up, people in the intervention group
were called opportunistically if they did not respond or attend,
which did not happen in the control group.
Hashimoto 2011 compared face-to-face check-ups with internet-
delivered check-ups for the specific purpose of tapering long-term
oral corticosteroid therapy (OCS), and for this reason we analysed
the study as a separate comparison. The study was designed to
test the effectiveness of a six-month programme of OCS adjust-
ment either via an internet diary and associated monitoring from
an asthma nurse or via face-to-face check-ups with a specialist ac-
cording to Global Initiative for Asthma (GINA) guidelines.
Excluded studies
We excluded 125 records after viewing full texts, which we col-
lated to represent 94 unique studies. The most common reason
for exclusion was that the intervention did not meet the inclu-
sion criteria (82 studies). Within this explanation, we explored
the reasons and found that we often excluded studies because they
used technology to facilitate self-monitoring between usual face-
to-face check-ups (n = 22), and these studies meet the inclusion
for another Cochrane review (Kew 2015a). Other excluded stud-
ies with interventions that did not meet the inclusion criteria used
technology as education rather than for asthma check-ups (n =
14), as automated monitoring systems without involvement from
a health professional (n = 8), to validate an asthma questionnaire
(n = 7), to improve or monitor adherence (n = 7), or to deliver a
range of other interventions that did not match the remit of this
review (including technology delivered counselling or behavioural
interventions, parenting advice and monitoring interventions de-
livered without technology). We excluded eight studies as they
were not RCTs (n = 8), and four because they made the wrong
comparison (n = 4).
Risk of bias in included studies
We have shown a summary of the ’Risk of bias’ judgements in
Figure 2.
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Figure 2. ’Risk of bias’ summary: review authors’ judgements about each ’Risk of bias’ item for each
included study.
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Allocation
We rated all the included studies at low risk of bias for random se-
quence generation as they described the randomisation methods,
such as centralised systems, random numbers tables or coin toss.
We judged two studies at low risk of bias for allocation conceal-
ment after the study authors responded to our request to clarify
the study methods. Also we considered one study at unclear risk of
bias because it did not adequately describe the methods. Regard-
ing Pinnock 2007a, the cluster implementation study, we rated it
at high risk of bias for allocation concealment because of its two-
cluster design.
Blinding
Due to the nature of the interventions, none of the included studies
were able to blind participants and personnel to group allocation
(performance bias). For this reason, we chose to assess blinding of
participants and personnel separately for the subjective and ob-
jective outcomes. In each study, we rated the subjective outcomes
(Asthma Control Questionnaire (ACQ) and Asthma Quality of
Life Questionnaire (AQLQ)) at high risk of bias and the objective
outcomes (exacerbations, adverse events, FEV1) at low risk of bias.
While it was possible for studies to blind outcome assessors (de-
tection bias), no included study described the procedures to do so.
Gruffydd-Jones 2005, Hashimoto 2011 (through personal com-
munication) and Rasmussen 2005 explicitly stated that the out-
comes assessors were not blinded to allocation so we rated them
at high risk of bias, and the remaining studies as unclear.
Incomplete outcome data
We considered two included studies at low risk of bias (Pinnock
2003; Pinnock 2007a). The former had low and even dropout, and
the latter was a real-world implementation studywhere uptake rate
was an integral part of the study. We rated four studies at high risk
of bias due to incomplete outcome data, either because dropout
was high or unbalanced between groups or missing data had not
been sufficiently imputed to account for those not in the study at
the end (or both) (Chan 2007; Gruffydd-Jones 2005; Hashimoto
2011; Rasmussen 2005). Due to the nature of the question being
posed in the studies, several were run in a real-world context which
made it more difficult to control for participants dropping out.
Selective reporting
There was no evidence of selective reporting in the six included
studies so we rated them at low risk of bias. Where outcomes
were unavailable in the published reports, the trial authors were
able to provide the additional data or confirm they had not been
measured.
Other potential sources of bias
We rated Pinnock 2007a at high risk of bias for several reasons
related to its cluster before-and-after study design. It randomised
two practices to the interventionswhichwould not have controlled
for baseline imbalances in the same way as individual randomisa-
tion, and this meant the participant population in each group was
not static. The intervention was a telephone option and many in
that practice opted for a usual face-to-face check-up, which meant
the study did not make a direct comparison of remote and face-
to-face check-ups. Additionally, people in the telephone option
group were phoned opportunistically to increase uptake of check-
ups, which did not happen in the face-to-face group. These factors
mean we cannot be certain that the mode of check-up, and not
the increased likelihood of being seen, was the variable measured
and we considered this study as having a high risk of bias. For
these reasons, we chose to present the study alongside the others
but not to pool its results in the main analyses.
We did not identify any other sources of bias in the five other
included studies, which we rated as having a low risk of bias.
Effects of interventions
See: Summary of findings for the main comparison Summary
of findings table
Wehave presented data from studies thatmade a direct comparison
between remote and face-to-face check-ups as the main results
(referred herein as the ’efficacy studies’, and supplemented these
by the results from the large two-cluster implementation study,
Pinnock 2007a. We have described data from the OCS tapering
study, Hashimoto 2011, as a separate comparison below.
Primary outcomes
Exacerbations that required oral corticosteroids
One efficacy study reported the number of people who needed
a course of oral corticosteroids for an exacerbation of asthma (
Pinnock 2003). The confidence intervals (CIs) were very wide due
to the small number of events in the analysis (odds ratio (OR) 1.74,
95% CI 0.41 to 7.44; 278 participants). In the face-to-face check-
up group, 21 people out of 1000 had exacerbations requiring oral
steroids over three months, compared to 36 (95% CI nine to 139)
out of 1000 in the remote group. We downgraded the evidence
to low quality due to imprecision. The effect from the cluster
implementation study was much more precise and favoured face-
to-face check-ups (OR1.43, 95%CI 1.04 to 1.97); we have shown
the two effects together in Analysis 1.1.
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Exacerbations that required emergency department (ED)
visit and hospital admission
The effect for exacerbations that required treatment in the ED also
favoured face-to-face check-ups over those conducted remotely,
but this was uncertain due to the wide CIs from a small number of
events (OR 2.60, 95% CI 0.63 to 10.64; 651 participants; three
studies; Analysis 1.2). The result of the cluster implementation
study was much smaller but also very imprecise (OR 1.19, 95%
CI 0.38 to 3.71; 1212 participants; one study). Too few people
in the efficacy studies had exacerbations that required a hospi-
tal admission to detect any difference between the two types of
check-up (Peto OR 0.63, 95% CI 0.06 to 6.32; 651 participants;
three studies; Analysis 1.3), and the cluster implementation study
showed a possible but not statistically significant benefit of face-
to-face check-up (Peto OR 2.18, 95% CI 0.83 to 5.69; 1213 par-
ticipants; one study).
Asthma control
There was no difference in scores on the Asthma Control Ques-
tionnaire (ACQ) between participants in the remote and face-to-
face groups (mean difference (MD) −0.07, 95% CI −0.35 to
0.21; 146 participants; one study; Analysis 1.4). Both CIs were
within the minimal clinically important difference (MCID) for
the scale (MCID = 0.5). We downgraded the quality of the evi-
dence to moderate quality due to risk of bias because the outcome
was a subjective rating scale that may have been affected by the
inability to blind participants and personnel to group allocation.
While the effect from the cluster implementation study was more
in favour of remote check-ups than the efficacy studies, the esti-
mate and its CIs were still within the MCID for the scale so the
difference was unimportant.
Serious adverse events (including mortality)
Only the cluster implementation study reported serious adverse
events (SAEs) and showed a higher number in participants in the
remote groups, although the CIs did not exclude the possibility
that they were more common with face-to-face check-ups (OR
1.80, 95% CI 0.73 to 4.44; 1213 participants; one study; Analysis
1.5). Given that SAEs are usually defined as those requiring hos-
pital admission, it is likely that most of these events were the ex-
acerbations requiring hospital admission described above.
Subgroup analyses
We were unable to conduct meaningful subgroup analyses on the
basis of age and type of technology as planned, as there was an
insufficient number of included studies to do this.
Sensitivity analyses
Severe or life-threatening asthma
It was not necessary to conduct this sensitivity analysis because
only Hashimoto 2011 specifically recruited people with severe or
life-threatening asthma and we analysed this study on its own due
to the nature of the intervention.
Unpublished data
The trial author of Pinnock 2007a provided additional data for
exacerbations requiring oral steroids, but we did not pool the study
effect with the other study in the analysis so there was no basis for
a sensitivity analysis.
High risk of selection bias
None of the included studies were at high risk of selection biases
so we did not perform the planned sensitivity analysis.
Secondary outcomes
Asthma-related quality of life
There was no difference between remote and face-to-face check-
ups on the Asthma Quality of Life Questionnaire (AQLQ) (MD
0.08, 95% CI −0.14 to 0.30; 544 participants; three studies;
Analysis 1.6). While the effect was marginally in favour of remote
check-ups, both CIs were within the 0.5minimal clinically impor-
tant difference on the scale. As with the ACQ, we downgraded the
evidence to moderate quality for risk of bias because the outcome
was subjective and may have been affected by lack of blinding.
The point estimate in the implementation study lay marginally in
the opposite direction but the result was not inconsistent given
the MCID (−0.02, 95% CI−0.23 to 0.19; 536 participants; one
study).
Rasmussen 2005 also reported the AQLQ but the data were
skewed and analysed non-parametrically so we could not com-
bine it with the other studies in the meta-analysis (internet group
median 6.42, range 4.11 to 7.00; specialist group median 6.17,
range 3.98 to 7.00; GP group median 6.31, range 1.41 to 7.00).
Chan 2007 also reported the parent version of the AQLQwith the
following scores (remote group: mean 6.4, SD = 1, N = 60; face-
to-face group: mean 6.2, SD = 0.8, N = 60). We considered the
child version to be more similar to the way the scores were taken
in the other studies which is why we included the child and not
the parent scores in the meta-analysis.
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Unscheduled healthcare visits
The pooled estimate from two efficacy studies was based on very
few events and was too imprecise to draw a conclusion (OR 0.91,
95% CI 0.45 to 1.85; 531 participants; two studies; Analysis 1.7).
The direction and magnitude of the effect from the implementa-
tion study were consistent but the estimate was more precise (OR
0.95, 95% CI 0.75 to 1.21; 1213 participants; one study).
Lung function (trough FEV1 preferred)
Only one efficacy study reported trough FEV1 (mL), and showed
a bigger improvement in the remote check-up group (MD166.76,
95% CI 78.03 to 255.50; 253 participants; one study; Analysis
1.8). We downgraded the evidence for imprecision to moderate
quality because it was based on only 253 people, even though
the confidence intervals excluded the possibility that face-to-face
check-ups were better. The implementation study was not de-
signed to measure lung function.
Adverse events/side effects
Studies generally did not report adverse events separately from the
asthma exacerbation and resource use outcomes.One study author
confirmed that no participants in either group experienced adverse
events, which did not allow us to display an effect estimate.
Remote versus face-to-face check-up for oral
corticosteroid tapering - analysis of Hashimoto 2011
We chose to assess Hashimoto 2011 separately from the other
studies as it was specifically aimed at assessing remote versus face-
to-face check-ups to guide dose reduction for people with asthma
taking long-term oral corticosteroids.
Mostly the CIs were too wide to tell whether one type of check-
up was better than the other at reducing harmful outcomes that
might occur as a result of withdrawing oral steroids, or to say that
they were equivalent. This was true for exacerbations requiring
hospital admission (OR 0.88, 95% CI 0.25 to 3.13; Analysis 2.1),
unscheduled healthcare visits (OR 2.31, 95% CI 0.23 to 23.14;
Analysis 2.4) and adverse events (OR 1.51, 95%CI 0.13 to 17.29;
Analysis 2.5). Scores on the ACQ (MD 0.14, 95% CI −0.15 to
0.43; Analysis 2.2) and AQLQ (MD −0.17, 95% CI −0.49 to
0.15; Analysis 2.3) were slightly better in the face-to-face group
than those who were managed remotely, but the difference was
below the minimal clinically important difference on both scales
and the CIs did not exclude the possibility that remote check-ups
were better.
D I S C U S S I O N
Summary of main results
Six studies met the inclusion criteria (including a total of 2100
participants): we pooled four studies in the main efficacy analyses,
which randomised 792 people to remote or face-to-face check-
up. In addition we also presented the results of a cluster imple-
mentation study (n = 1213) alongside the main results but did
not pool them with the other included studies, and assessed one
study that compared the two types of check-up for oral steroid
tapering in severe refractory asthma as a separate comparison (n =
95). Baseline characteristics relating to asthma severity were vari-
able, but studies generally recruited people with asthma who took
regular medications and excluded those with chronic obstructive
pulmonary disease (COPD) or severe asthma. The studies could
not be blinded and dropout was high in four of the six included
studies, which may have biased the results.
We cannot say whether more people in the remote groups needed
oral corticosteroids for an asthma exacerbation than those seen
face-to-face because the confidence intervals (CIs) were very wide
(OR 1.74, 95% CI 0.41 to 7.44; 278 participants; one study; low
quality evidence). In the face-to-face check-up groups, 21 people
out of 1000 had exacerbations that required oral steroids over three
months, compared to 36 (95% CI nine to 139) out of 1000 for
the remote check-up group. Exacerbations that needed treatment
in the hospital emergency department (ED), hospital admission
or an unscheduled healthcare visit happened too infrequently to
detect whether remote check-ups are a safe alternative to face-
to-face consultations. Serious adverse events were not reported
separately from the exacerbation outcomes.
Therewas nodifference in asthma controlmeasured by theAsthma
ControlQuestionnaire (ACQ) or in quality of lifemeasured on the
Asthma Quality of Life Questionnaire (AQLQ) between remote
and face-to-face check-ups. We ruled out the significant harm of
remote check-ups for these outcomes but we were less confident
because these outcomes are more prone to bias from lack of blind-
ing.
The larger implementation study that compared two general prac-
tice populations demonstrated that offering telephone check-ups
and proactively phoning participants increased the number of peo-
ple with asthma who received a review. However, we do not know
whether the additional participants who had a telephone check-
up subsequently benefited in asthma outcomes.
Overall completeness and applicability of
evidence
The design of this Cochrane review allowed us to focus on the spe-
cific question of whether regular asthma check-ups can effectively
be conducted remotely as opposed to face-to-face. By honing in
on this form of telehealth, we were able to assess the evidence for a
clearly defined application of technology-based care that was more
likely to lead to evidence that could be readily applied to real world
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settings. However, it did limit our assessments of possible effect
moderators, such as age and type of technology, due to the small
number of studies that met the inclusion criteria and reported the
primary outcomes.
As described in the ’Included studies’ section, Pinnock 2007a was
a real-word implementation study that differed from the other in-
cluded studies in several respects. We chose to include this study
because it addressed the feasibility of remote check-ups in a real-
world setting, despite its design being dissimilar to the other in-
cluded studies. By not pooling it with the other studies but pre-
senting the results alongside them, we hoped to highlight the pos-
sible differences in a controlled comparison of remote and face-to-
face check-ups and what might actually happen in practice. While
Pinnock 2007a’s results do not lead to the cause and effect infer-
ences that can be made from the efficacy RCTs, it does give an
important insight into the relative merits of a possible incorpora-
tion of remote check-ups into practice, and we consider the review
to be more complete as a result. We did not set out to assess the
possible benefit of improving access by offering remote check-ups,
especially for patients who are less likely to attend their annual
check-up. This is an important factor that can be addressed by
implementation studies, such as Pinnock 2007a, better than clas-
sic randomised controlled trials (RCTs). Unfortunately, because
there were only two clusters, the study results must be interpreted
with caution and with the caveats both in this Cochrane review
and in the study itself.
One efficacy study contributed data to the exacerbations requiring
oral steroids analysis and this was provided by the study author
(Pinnock 2003). It was not always possible to distinguish between
courses of oral steroids for immediate treatment or future use (as
part of an action plan). This highlights the importance of con-
tacting study authors for additional data, as their own primary
outcomes may differ from those of the review. This increased the
completeness of the evidence base and our confidence in the re-
sults.
Quality of the evidence
We rated the evidence in this Cochrane review as low or moderate
quality,mostly due to imprecision or risk of bias.We chose to assess
blinding for the subjective outcomes separately from the objective
outcomes. By differentiating the outcomes in this way, we were
able to assess the effect lack of blinding was likely to have had on
the confidence we have in the results. For the objective outcomes,
we noted that the study designs did not allow for blinding of
participants and personnel, but judged that this lack of blinding
is unlikely to have made a difference to the number of people
who had exacerbations, adverse events and lung function. There
is a possibility that the lack of blinding may have still affected
the way these outcomes were recorded but we did not consider
this to sufficient to downgrade the evidence. For the subjective
outcomes, it is more likely that the participant or investigators’
knowledge of group allocation could have affected the way they
responded to the asthma control and quality of life questionnaires,
so we downgraded these outcomes for risk of bias.
We downgraded five outcomes for imprecision, including the pri-
mary outcome. We were fairly certain in the direction of the effect
for the primary outcome, exacerbations requiring oral steroids,
but there was only one efficacy study in the analysis and seven
events, which reduced our confidence in the size and precision of
the estimate significantly. Exacerbations that required an ED visit
or a hospital admission, and unscheduled healthcare visits were all
based on a very small number of events, which crucially meant we
could not rule out significant harm of conducting remote check-
ups for people with asthma. Finally, we downgraded trough FEV1
for imprecision for a similar reason to the primary outcome: the
effect was in favour of remote check-ups, but the estimate was
based on just one study of 253 people, so we weren’t confident
in the result. Visually, there was imprecision in the estimates for
asthma control and quality of life, but the CIs for both were well
with the established minimal clinically important differences for
the scales (Juniper 1994; Juniper 1999).
We did not downgrade any of the outcomes for publication bias,
inconsistency in the results or indirectness of the evidence. While
not all studies reported the outcomes we were interested in, this
wasmore likely to reflect the individual practices and designs of the
studies (e.g. unable tomeasure lung function remotely) rather than
selective reporting of outcome data. There was minimal statistical
inconsistency in the analyses, and while there was a fair amount
of variation in the aims and designs of the studies, we considered
them all to match the PICO set out in the protocol for this review
(Kew 2015b).
Potential biases in the review process
We made every effort to adhere to Cochrane methods during the
review process. Both review authors extracted numerical data, per-
formed ’Risk of bias’ ratings in duplicate, and cross checked for
accuracy and consistency. Throughout the process, we resolved
any discrepancies through discussion. Neither review author has
any conflicts of interest relating to this Cochrane review.
We performed broad literature searches that we independently
screened in duplicate, and included studies regardless of language
of publication or the existence of a full-text paper. We also con-
ducted comprehensive additional searches to identify unpublished
studies that were not listed in the main electronic databases. It is
unlikely that we missed studies during the study selection process,
except for those not listed in non-English language databases. We
made every effort to contact study authors, although in some cases
this was difficult due to when the studies were conducted and the
effect this had both on the availability of contact details and the
likelihood we could obtain data. We received detailed replies from
two study authors which affected several analyses and the com-
pleteness of the ’Risk of bias’ information.
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Agreements and disagreements with other
studies or reviews
Systematic reviews of the evidence for remote asthma check-ups
have generally had much broader inclusion criteria, assessing the
use of any kind of telehealthcare for monitoring or educating peo-
ple with asthma. As such, it is difficult to compare the results of
this Cochrane review with their results because we designed this
systematic review to assess specifically the use of technology sys-
tems to conduct asthma check-ups remotely. For example,McLean
2010 included 21 studies that assessed a range of telehealth in-
terventions against a range of control groups, and as such it was
difficult to meta-analyse the data in a way that led to conclusions
with real-world implications.
Systematic reviews that examined telehealth more broadly for
asthma have generally approached the question from a different
standpoint from our own. Other reviews have focused on possible
benefits of remote healthcare over usual face-to-face care, whereas
we were more concerned with highlighting the potential dangers
of removing face-to-face contact with a healthcare professional.
Conclusions made by McLean 2010 regarding the lack of bene-
fit for relatively mild asthma and Zhao 2014 regarding the lack
of improvements on asthma function scores do not disagree with
our own, but are framed from the former standpoint. This is at
least partly because these two reviews did not set out to compare
remote or ’telehealthcare’ against a consistent alternative form of
monitoring. For most outcomes we looked at, we cannot conclude
that remote check-ups definitely lead to worse outcomes than face-
to-face care, but neither can we conclude that remote check-ups
are a safe alternative to face-to-face care for either mild or severe
asthma.
In their conclusions, Jaana 2009 focused on the attitudes and re-
ceptiveness of home telemonitoring for patients with respiratory
illness, which we did not set out to assess, and commented on the
”variations in study approaches and an absence of robust study
designs and formal evaluations“. We agree that the inherent differ-
ences in health systems and study designs continue to limit con-
clusions in this field, even when review questions are refined to
one part of ’telehealthcare’.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Current randomised evidence does not demonstrate any important
differences between face-to-face and remote asthma check-ups in
terms of exacerbations, asthma control or quality of life. There is
insufficient information to rule out differences in efficacy, or to
say whether or not remote asthma check-ups are a safe alternative
to usual face-to-face consultations.
Implications for research
It would be helpful to find out whether remote check-ups for peo-
ple with asthma who do not attend for a face-to-face consultation
can achieve a reduction in the risk of serious asthma attacks that
result in hospital admissions. To do this, further studies are re-
quired in high-risk people with frequent asthma admissions who
do not attend for regular face-to-face check-up. It might be sensi-
ble to include remote monitoring and remote check-ups in the in-
tervention as it seems unlikely that remote check-ups alone would
be sufficient to reduce admissions to hospital.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chan 2007
Methods Study design: 12 month parallel RCT
Setting: paediatric clinic at Tripler Army Medical Center, Hawaii
Enrolment began in March 2003 and ended in December 2003. Participant data collec-
tion ended with the last participant’s final visit in February 2005
Participants Population: 120 children were randomised to the virtual group (60) or the office-based
group (60)
Baseline characteristics:
mean age, years (SD): remote 10.2 (3.1); face-to-face 9.0 (3.0)
% male: remote 61.7; face-to-face 63.3
% predicted FEV1 (SD): remote 104.1 (19.9); face-to-face 96.8 (13.0)
Inclusion criteria: children aged 6 to 17 years with persistent asthma, dependent of
active duty or retired USA military personnel, not moving from Oahu for 12 months
after entry into the study, ability to receive cable modem connections in the home,
willingness to complete questionnaires and monitoring
Exclusion criteria: none stated
Interventions Intervention: virtual group participants received computers, internet connections and
in-home internet-based case management and received education through the study
website
Control: office-based group patients received traditional in-person education and case
management
Outcomes Control medication use, daily symptom diary, peak flow, patient and caregiver AQLQ,
service utilisation, asthma knowledge retention
Measured at 2 weeks, 6 weeks, 3 months, 6 months and 12 months
Notes Funding: grant from the US Army Medical Research Acquisition Activity
ID number(s): N/A
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ”patients underwent block randomisation
with a table of random numbers“
Allocation concealment (selection bias) Unclear risk The study did not provide any details.
Blinding of participants and personnel
Objective outcomes
Low risk It would not have been possible to blind
participants and personnel to allocation
due to the nature of the intervention.
However, participants and personnel being
aware of group allocation is unlikely to have
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affected the results for the objective out-
comes (exacerbations and adverse events)
Blinding of participants and personnel
Subjective outcomes
High risk Participants and personnel being aware
of group allocation could have affected
their scores on subjective outcomes such
as those measured on self-report scales
(Asthma Control Questionnaire (ACQ)
and AQLQ)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is possible to blind outcome assessment
but the study did not provide any specific
details of whether this was done
Incomplete outcome data (attrition bias)
All outcomes
High risk Dropout was much higher in the virtual
group (23%) than the office group (8%).
The study authors did not account for non-
adherent participants and other dropouts
in the analysis
Selective reporting (reporting bias) Low risk Outcomes were well reported. There was
no protocol registration available to check
all pre-specified measures were included
but there was no evidence of selective re-
porting
Other bias Low risk We did not note any other possible sources
of bias.
Gruffydd-Jones 2005
Methods Study design: 12 month parallel RCT
Setting: 1 practice in England, UK
Participants were recruited between December 2002 and March 2003
Participants Population: 194 people were randomised to the telephone group (97) or the clinic group
(97)
Baseline characteristics:
mean age, years (standard deviation (SD)): remote 50.8 (15.4); face-to-face 49.6 (16.1)
% male: remote 51.5; face-to-face 39.2
% predicted forced expiratory volume in one second (FEV1) (SD): not reported
Inclusion criteria: adults with asthma aged 17 to 70 years and on the practice asthma
list
Exclusion criteria: housebound, did not possess a telephone or were unwilling to give
informed consent
Interventions Intervention: participants were contacted by telephone at 6-monthly intervals by 1 of
2 trained asthma nurses. The participant was then asked the RCPs ‘three questions’ plus
two extra questions related to a high risk of asthma death. The nurse formulated an
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individualised asthma action plan with the participant, with advice on what to do if
asthma control deteriorated
Control: participants received usual care by 6-monthly check up via a dedicated asthma
appointment with a diploma-level asthma nurse. Symptom scores, inhaler technique and
peak flow measurements were checked and all participants issued with an asthma action
plan
Outcomes ACQ,mini-AQLQ,mild and severe exacerbations, healthcare costs, clinical time, inhaler
use, unscheduled healthcare visits all given per patient year
Measured at baseline, 6 months and 12 months
Notes Funding: grant from Asthma UK
ID number(s): N/A
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The study randomised participants using a
random number tables on a 1 to 1 basis and
stratified according to severity
Allocation concealment (selection bias) Unclear risk The study did not provide any details.
Blinding of participants and personnel
Objective outcomes
Low risk It would not have been possible to blind
participants and personnel to allocation
due to the nature of the intervention.
However, participants and personnel being
aware of group allocation is unlikely to have
affected the results for the objective out-
comes (exacerbations and adverse events)
Blinding of participants and personnel
Subjective outcomes
High risk Participants and personnel being aware of
group allocation could have affected their
scores on subjective outcomes such as those
measured on self-report scales (ACQ and
AQLQ)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk ”assessors were not blinded to the interven-
tions due to limited resources“
Incomplete outcome data (attrition bias)
All outcomes
High risk ”There were 20 withdrawals in the con-
trol group after the first visit, mainly due
to non-attendance and 6 in the telephone
group, one of which was due to non-atten-
dance. As this trial is as real-world as pos-
sible the fact that there was a high non-
attendance rate was taken account of in
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analysing the costs.“
Selective reporting (reporting bias) Low risk Outcomes were well reported. There was
no protocol registration available to check
all pre-specified measures were included
but there was no evidence of selective re-
porting
Other bias Low risk We did not note any other possible sources
of bias.
Hashimoto 2011
Methods Study design: pragmatic 6 month parallel RCT
Setting: 2 academic tertiary care hospitals and 4 large community hospitals in The
Netherlands
Participants were randomised between November 2007 and October 2008
Participants Population: 95 people were randomised to the internet group (52) or the conventional
face-to-face management group (38)
Baseline characteristics:
mean age, years (SD): remote 48.5 (12.4); face-to-face 52.4 (11.7)
% male: remote 45; face-to-face 47
% predicted FEV1 (SD): remote 76.3 (24.7); face-to-face 71.3 (21.0)
Inclusion criteria: adults (18 to 75 years) with a diagnosis of severe refractory asthma
according to the major and minor criteria recommended by the American Thoracic
Society. They haduncontrolled asthmadespite intensive follow-upby an asthma specialist
for at least 1 year, chronic treatment with oral corticosteroids and high doses of ICS plus
long-acting bronchodilators. All were non-smokers with a maximum smoking history
of 15 pack-years and had access to internet or mobile telephone
Exclusion criteria: none stated
Interventions Intervention: dose adjustment of oral corticosteroids guided by an internet-based man-
agement tool (internet group). Included electronic diary, decision support and monitor-
ing support by a study nurse
Control: dose adjustment of oral corticosteroids according to conventional asthma treat-
ment by the pulmonologist, according to GINA (conventional management group)
Outcomes Cumulative sparing of oral corticosteroid therapy (OCS), ACQ, AQLQ, global satisfac-
tion scale, FEV1, number of exacerbations and days of hospitalisation
The authors defined an exacerbation as a decrease in morning FEV1 of at least 10%
compared with the mean FEV1 from the week before, or a respiratory event requiring an
increase in prednisone equivalent to at least 10 mg/day, or a course of antibiotics, with
or without hospitalisation
Notes Funding: The Netherlands Organization for Health Research and Development
(ZonMw)
ID number(s): 1146 (Netherlands Trial Reg No.)
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The study randomised participants by a
computer random number generator and
remained on the same allocation through-
out the study. Communication: ”The ran-
dom codes were stratified for study cen-
ter and initial dose of corticosteroid dose
(lower or higher than 10mgprednisone per
day)“
Allocation concealment (selection bias) Unclear risk ”unblinded after randomisation“, implies
it was concealed, but the study did not pro-
vide any further details
Blinding of participants and personnel
Objective outcomes
Low risk The treatment assignments were unblinded
after randomisation to allow monthly cor-
ticosteroid dose adjustments according to
conventional treatment by the physician or
weekly adjustments according to the inter-
net algorithm. While it was not possible to
blind participants and personnel to alloca-
tion due to the nature of the intervention,
participants and personnel being aware of
group allocation is unlikely to have affected
the results for the objective outcomes (ex-
acerbations and adverse events)
Blinding of participants and personnel
Subjective outcomes
High risk Participants and personnel being aware of
group allocation could have affected their
scores on subjective outcomes such as those
measured on self-report scales (ACQ and
AQLQ)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Communication: ”This was a pragmatic
study so the outcome assessors were not
blind to the group allocation in order to
allow monthly corticosteroid dose adjust-
ments (according to conventional treat-
ment by the physician) or weekly adjust-
ments (according to the internet algorithm)
“
Incomplete outcome data (attrition bias)
All outcomes
High risk Five participants in the conventional man-
agement group withdrew consent before
the study had started and the study ex-
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cluded one participant because of poor ad-
herence to the trial protocol. The study in-
cluded 89 participants out of 95 in the in-
tention-to-treat (ITT) analysis; 51 and 38.
Dropout was higher in the conventional
treatment group (16% versus 8%)
Selective reporting (reporting bias) Low risk The study was prospectively registered, and
outcomes were well reported
Other bias Low risk We did not note any other possible sources
of bias.
Pinnock 2003
Methods Study design: pragmatic parallel RCT (duration of study participation varied across
participants)
Setting: 4 general practices in the UK
Participants Population: 278 people were randomised to remote telephone check-up (137) or face-
to-face check-up (141)
Baseline characteristics:
mean age, years (SD): remote 54.6 (17.5); face-to-face 56.4 (17.5)
% male: remote 41; face-to-face 42
% predicted FEV1 (SD): not reported
Inclusion criteria: adults with asthma who had requested a prescription for a bron-
chodilator inhaler in the last 6 months
Exclusion criteria: if diagnosis of asthma had been made within the previous year, if
they had chronic obstructive pulmonary disease, if communication difficulties made a
telephone check-up impossible, or (at the general practitioner’s (GP’s) request) for major
social or medical reasons
Interventions Intervention: telephone check-up with the asthma nurse. The nurse tried up to 4 times
to contact the participants
Control: face-to-face check-ups in the surgery also with the asthma nurse, one invita-
tion was sent in the usual manner. Content of the check-up was as the nurse deemed
appropriate
Outcomes Medical reviews, time taken to review participants in each arm, asthma morbidity on
the short Q, asthma related quality of life on the mini AQLQ, participant satisfaction,
costs
Notes Funding: originally developed at a General Practice Airways Group research meeting,
whichwas organised byMarkLevy and fundedby an educational grant fromAstraZeneca.
The trial was funded by British Lung Foundation (Grant No P00/9). Additionally, one
study author was supported by an NHS R&D national primary care fellowship.
ID number(s): N/A
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were centrally randomised in
blocks of 10 to ensure that approximately
equal numbers of participants were allo-
cated to each study arm
Allocation concealment (selection bias) Low risk ”Centrally randomised“ implies that allo-
cation was undertaken independently and
concealed
Blinding of participants and personnel
Objective outcomes
Low risk It would not have been possible to blind
participants and personnel to allocation
due to the nature of the intervention.
However, participants and personnel being
aware of group allocation is unlikely to have
affected the results for the objective out-
comes (exacerbations and adverse events)
Blinding of participants and personnel
Subjective outcomes
High risk Participants and personnel being aware of
group allocation could have affected their
scores on subjective outcomes such as those
measured on self-report scales (ACQ and
AQLQ)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk “a researcher, blinded to allocation visited
each of the practices and validated a ran-
dom 20% sample of consultation data and
data retrieved from records”. However, the
participants and investigators could not
be blinded to the interventions and, in
most cases, the outcome assessors were not
blinded to group allocation either
Incomplete outcome data (attrition bias)
All outcomes
Low risk The percentage of withdrawals was low and
even between groups (5.1 and 4.3% in
the remote and face-to-face groups respec-
tively)
Selective reporting (reporting bias) Low risk There was no evidence of selective report-
ing.
Other bias Low risk We did not note any other possible sources
of bias.
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Methods Study design: 12 month before-and-after implementation study
Setting: 1 large English general practice on 3 sites
Participants Population: 3 practices were randomised to: 1. a choice of remote phone check-ups or
face-to-face check-ups (554 on list), 2. face-to-face only check-ups (659 on list), or 3. a
usual care control group which was not included in this systematic review (515 on list)
Baseline characteristics:
mean age, years (SD): remote 43 (24.8); face-to-face 42.3 (24.4)
% male: remote 44.2; face-to-face 44.9
% predicted FEV1 (SD): not reported
Inclusion criteria: adults and adolescents with a diagnosis of asthma and prescribed
asthma medication in the previous year
Exclusion criteria: children under 12 years of age, diagnosis of COPD
Interventions Intervention: participants were identified from the practice computer database and sent
3 invitations over the study period. They could book either a telephone or face-to-
face check-up both at a pre-arranged time. Participants who did not respond to the 3
invitations were phoned and reviewed opportunistically
Control: participants were recalled to face-to-face only asthma check-ups using invita-
tions by post or as memos with repeat prescriptions. There was no option of telephone
check-ups and no systematic attempt was made to phone non-attenders opportunisti-
cally
Group excluded: the usual-care control group maintained their well established asthma
clinic, and existing procedures (for example, invitations are issued in response to clinical
need), but no systematic recall was undertaken
Outcomes Proportion reviewed, asthma morbidity and enablement on the mini AQLQ, ACQ,
modified patient enablement instrument and Asthma Bother Profile, adverse events,
costs
Notes Funding: Scientific Foundation Board of the Royal College of General Practitioners
(SFB/2003/45)
ID number(s): N/A
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The study decided allocation to the tele-
phone option by the public toss of a coin
Allocation concealment (selection bias) High risk The study allocated individuals to treat-
ment after the two clusters had been de-
cided by the toss of a coin
Blinding of participants and personnel
Objective outcomes
Low risk It would not have been possible to blind
participants and personnel to allocation
due to the nature of the intervention.
However, participants and personnel being
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aware of group allocation is unlikely to have
affected the results for the objective out-
comes (exacerbations and adverse events)
Blinding of participants and personnel
Subjective outcomes
High risk Participants and personnel being aware of
group allocation could have affected their
scores on subjective outcomes such as those
measured on self-report scales (ACQ and
AQLQ)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk The nurses were aware of allocation but it
was unclear whether it was the nurses mea-
suring outcomes, or if it was someone inde-
pendent from the study who could remain
blind to allocation. The study did not de-
scribe this. The study stated that there were
quality control checks blinded to allocation
which confirmed accuracy of data transfer
Incomplete outcome data (attrition bias)
All outcomes
Low risk Real-world implementation study, there-
fore the uptake rate by participants is part
of the study, routine asthma check-up was
provided for 66.3% of participants in the
telephone only group and 53.8% in the
face-to-face only group
Selective reporting (reporting bias) Low risk There was no evidence of selective report-
ing.
Other bias High risk This study was a cluster implementation
studywith a before-and-after design. It ran-
domised 2 practices to the interventions
which would not have controlled for base-
line imbalances in the same way as individ-
ual randomisation, and this meant the par-
ticipant population in each group was not
static. The interventionwas a telephone op-
tion and many in that practice opted for a
usual face-to-face check-up, which meant
the study was not making a direct compar-
ison of remote and face-to-face check-ups.
Additionally, people in the telephone op-
tion group were phoned opportunistically
to increase uptake of check-ups which did
not happen in the face-to-face group.These
factors mean we cannot be certain that
mode of check-up, and not the increased
likelihood of check-up, was the variable be-
ing measured
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Rasmussen 2005
Methods Study design: 6 month pragmatic parallel RCT
Setting: general practices and specialist clinics in Copenhagen, Denmark
Participants Population: 300 people were randomised to remote check-ups (100), face-to-face check-
ups with a specialist (100), and a usual care group not included in this review (100)
Baseline characteristics:
mean age, years (SD): remote 28 (NR); face-to-face 30 (NR)
% male: remote 31.8; face-to-face 34.1
% predicted FEV1 (SD): remote 91 (NR); face-to-face 93 (NR)
Inclusion criteria: 18 to 45 years with definite asthma, living in the catchment area of
H:S Bispebjerg University Hospital of Copenhagen, Denmark
Exclusion criteria: none stated
Interventions Intervention: participants were given a Peak FlowMeter and taught how to fill in a daily
diary and respond to the computer’s advice. Physicians gave instructions via e-mail or
telephone to the participant. The intervention included an electronic diary, an asthma
action plan and a decision support system for the physician
Control: the specialists taught the participants how to adjust their medication on the
basis of a peak flow meter and written action plan
Group not included: the GP group was asked to contact their GP and pass on a letter
describing the study and giving the test results. GPs in Copenhagen had been sent a
circular about asthma and GINA guidelines in the past
Outcomes AQLQ, asthma self-care, smoking, education, salary, sick leave, hospitalisations, medi-
cation compliance, adverse events, lung function
Measured at baseline and 6 months
Notes Funding: Grants from H:S Corporation of University Hospital of Copenhagen, As-
traZeneca, and private funds
ID number(s): N/A
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Communication:
”The allocation sequences were computer-
generated by a senior respiratory physician.
These sequences consisted of randomised
blocks of 30 asthmatics“
Allocation concealment (selection bias) Low risk Communication: ”The envelopes were
packed by twomedical students onemonth
before the start of the study and the ran-
domisation lists were stored in a separate,
sealed envelope. The consecutively num-
bered and sealed envelopes contained the
randomisation code. All envelopes were
opened sequentially after the asthma diag-
nosis had been verified“
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Blinding of participants and personnel
Objective outcomes
Low risk It would not have been possible to blind
participants and personnel to allocation
due to the nature of the intervention.
However, participants and personnel being
aware of group allocation is unlikely to have
affected the results for the objective out-
comes (exacerbations and adverse events)
Blinding of participants and personnel
Subjective outcomes
High risk Participants and personnel being aware of
group allocation could have affected their
scores on subjective outcomes such as those
measured on self-report scales (ACQ and
AQLQ)
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Communication: ”It was not possible to
blind outcome assessors to group alloca-
tion“
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the 300 participants randomised, 253
participants completed both the screening
and follow-up visits. Dropout was unbal-
anced across groups (12%, 15% and 20%)
, and the study does not appear to have im-
puted data for missing values
Selective reporting (reporting bias) Low risk The paper did not report all of the results
from the questionnaires but the lead study
author provided them on request
Other bias Low risk We did not note any other possible sources
of bias.
Abbreviations: ACQ = Asthma Control Questionnaire; AQLQ = Asthma Quality of Life Questionnaire; COPD = chronic obstructive
pulmonary disease; FEV1 = forced expiratory volume in one second; GINA =Global Initiative for Asthma; GP = general practitioner;
ICS = inhaled corticosteroids; ITT = intention-to-treat analysis; NR = not reported; OCS = oral corticosteroids; RCP = respiratory
care practitioner; RCT = randomised controlled trial; SD = standard deviation.
Characteristics of excluded studies [ordered by study ID]
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Study Reason for exclusion
ACTRN12606000400561 Wrong intervention - technology-based self management between reviews
Ahmed 2011 Wrong intervention - technology-based self management between reviews
Andersen 2007 Wrong intervention - minimal or no provider involvement
Apter 2000 Wrong design - not a trial report
Apter 2015 Wrong comparison - telemedicine portal used with or without home visits (both groups used the portal)
Araujo 2012 Wrong design - crossover RCT
Baptist 2013 Wrong comparison - phone calls for asthma education versus non-asthma phone calls
Barbanel 2003 Wrong intervention - asthma education intervention led by a pharmacist
Bateman 2000 Wrong intervention - technology-based self management between reviews
Bender 2001 Wrong intervention - study assessing validity of self-reports
Bender 2007 Wrong intervention - study assessing validity of self-reports
Bender 2010 Wrong intervention - minimal or no provider involvement
Boyd 2014 Wrong intervention - pharmacist led intervention about adherence
Burbank 2012 Wrong intervention - focus on asthma education, not monitoring with remote reviews
Burkhart 2002 Wrong intervention - intervention to improve adherence to home PEF measurements
Bynum 2001 Wrong intervention - pharmacy led technology intervention to improve adherence
Chandler 1990 Wrong intervention - monitoring theophylline levels
Chatkin 2006 Wrong intervention - phone calls to promote adherence, not remote reviews
Chen 2013 Wrong intervention - asthma behavioural intervention using technology, not remote reviews
Cicutto 2009 Wrong intervention - not remote reviews
Clark 2007 Wrong intervention - counselling intervention not remote reviews
Clarke 2014 Wrong intervention - parenting intervention, not remote reviews
Claus 2004 Wrong design - not a randomised controlled trial (RCT)
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Cruz-Correia 2007 Wrong design - crossover RCT
de Jongste 2008 Wrong comparison - comparing 2 types of electronic monitoring (FeNo versus symptoms)
De Vera 2014 Wrong intervention - asthma education and adherence monitoring by a pharmacist
Deschildre 2012 Wrong intervention - technology-based self management between reviews
Donald 2008 Wrong intervention - technology-based self management between reviews
Dwinger 2013 Wrong intervention - coaching/education interventionusing technology formultiple chronic conditions
Eakin 2012 Wrong intervention - not remote asthma reviews
Finkelstein 2005 Wrong intervention - technology-based self management between reviews
Fonseca 2006 Wrong design - survey of RCT participants
Foster 2014 Wrong intervention - adherence intervention
Friedman 1999 Wrong intervention - mostly automated home monitoring, not remote reviews
Garbutt 2010 Wrong intervention - asthma coaching/education intervention over the phone, not remote reviews
Guendelman 2002 Wrong intervention - technology-based self management between reviews
Gustafson 2012 Wrong intervention - self-determination theory intervention, not remote reviews
Halterman 2012 Wrong intervention - technology-based self management between reviews
Huang 2013 Wrong intervention - support intervention, not remote reviews
Jan 2007 Wrong intervention - technology-based self management between reviews
Janevic 2012 Wrong intervention - management intervention for African American women, not remote reviews
Jerant 2003 Wrong intervention - mixed diagnosis study comparing models of delivering home care
Kattan 2006 Wrong intervention - minimal or no provider involvement
Khan 2003 Wrong intervention - one phone call at discharge, not remote reviews
Kojima 2005 Wrong intervention - not technology-based
Kokubu 1999 Wrong intervention - technology-based self management between reviews
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Lam 2011 Wrong design - cross-sectional analysis of an ongoing RCT, and mixed diagnosis
Liu 2011 Wrong intervention - technology-based self management between reviews
Lobach 2013 Wrong intervention - not about remote reviews
McCowan 2001 Wrong intervention - computer-aided decision support during consultation
McPherson 2006 Wrong intervention - asthma education delivered via CD-ROM and book versus book alone
Merchant 2013 Wrong intervention - remote monitoring of inhaler adherence
Morrison 2014 Wrong intervention - minimal or no provider involvement
Murphy 2001 Wrong design - comment on a RCT
NCT00149474 Wrong comparison - remote monitoring using PEF or symptoms
NCT00232557 Wrong comparison - phone monitoring plus asthma education versus phone education
NCT00411346 Wrong intervention - technology-based self management between reviews
NCT00562081 Wrong intervention - focus on asthma education not remote reviews
NCT00910585 Wrong intervention - focus on asthma education not remote reviews
NCT00964301 Wrong intervention - focus on asthma education not remote reviews
NCT01117805 Wrong intervention - counselling not remote reviews
Neville 1996 Wrong intervention - computer-aided decision support during consultation
Osman 1997 Wrong intervention - post admission follow-up
Ostojic 2005 Wrong intervention - technology-based self management between reviews
Pedram 2012 Wrong intervention - main focus of the study was to educate participants on how to use a peak flow
meter
Peruccio 2005 Wrong intervention - treatment awareness education delivered over the phone
Petrie 2012 Wrong intervention - minimal or no provider involvement
Prabhakaran 2009 Wrong intervention - technology-based self management between reviews
Price 2007 Wrong intervention - validating the Asthma Control Test for internet use
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Raat 2007 Wrong design - questionnaire not a RCT
Rand 2005 Wrong intervention - study measuring validity of self-report
Ricci 2001 Wrong intervention - technology-based self management between reviews
Rikkers-Mutsaerts 2012 Wrong intervention - minimal or no provider involvement
Rosenzweig 2008 Wrong intervention - validation study
Ryan 2012 Wrong intervention - technology-based self management between reviews
Schatz 2003 Wrong comparison - phone calls on top of face-to-face review, not instead of
Schatz 2010 Wrong intervention - letter regarding validation of telephone delivery of the Asthma Control Ques-
tionnaire (ACQ)
Searing 2012 Wrong intervention - minimal or no provider involvement
Seid 2012 Wrong intervention - asthma education and motivational interviewing, not remote reviews
Shanovich 2009 Wrong intervention - focus on asthma education not remote reviews
Taitel 2014 Wrong intervention - pharmacy-led compliance intervention, not remote reviews
Uysal 2013 Wrong intervention - validating the Asthma Control Test via text messaging
van den Berg 2002 Wrong intervention - general practitioner (GP) telephone access to paediatricians
van der Meer 2009 Wrong intervention - technology-based self management between reviews
van Gaalen 2012 Wrong intervention - multifaceted intervention, not just remote reviews
van Reisen 2010 Wrong intervention - multifaceted intervention, not just remote reviews
Vasbinder 2013 Wrong intervention - minimal or no provider involvement. Medication reminder system
Vollmer 2006 Wrong intervention - technology-based self management between reviews
Voorend-van Bergen 2013 Wrong intervention - FeNO and Internet-based monitoring
Wiecha 2007 Wrong intervention - multi-faceted intervention, not just about remote monitoring
Willems 2008 Wrong intervention - technology-based self management between reviews
Young 2012 Wrong intervention - technology-based self management between reviews
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Yun 2013 Wrong intervention - asthma education via text, not remote reviews
Zachgo 2002 Wrong intervention - computer works out best inhaler type for patient
Abbreviations: RCT = randomised controlled trial; PEF = peak expiratory flow.
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D A T A A N D A N A L Y S E S
Comparison 1. Remote versus face-to-face asthma reviews
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Exacerbations requiring oral
corticosteroids
2 Odds Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Efficacy randomised
controlled trials (RCTs)
1 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Cluster implementation
study
1 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Exacerbations requiring hospital
emergency department (ED)
treatment
4 Odds Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Efficacy RCTs 3 651 Odds Ratio (M-H, Random, 95% CI) 2.60 [0.63, 10.64]
2.2 Cluster implementation
study
1 1212 Odds Ratio (M-H, Random, 95% CI) 1.19 [0.38, 3.71]
3 Exacerbations requiring hospital
admission
4 Peto Odds Ratio (Peto, Fixed, 95% CI) Subtotals only
3.1 Efficacy RCTs 3 651 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.63 [0.06, 6.32]
3.2 Cluster implementation
study
1 1213 Peto Odds Ratio (Peto, Fixed, 95% CI) 2.18 [0.83, 5.69]
4 Asthma control (Asthma Control
Questionnaire (ACQ))
2 Mean Difference (IV, Random, 95% CI) Totals not selected
4.1 Efficacy RCTs 1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.2 Cluster implementation
study
1 Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
5 Serious adverse events (including
mortality)
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
5.1 Cluster implementation
study
1 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6 Asthma-related quality of
life (Asthma Quality of Life
Questionnaire (AQLQ)
4 Mean Difference (IV, Random, 95% CI) Subtotals only
6.1 Efficacy RCTs 3 544 Mean Difference (IV, Random, 95% CI) 0.08 [-0.14, 0.30]
6.2 Cluster implementation
study
1 536 Mean Difference (IV, Random, 95% CI) -0.02 [-0.23, 0.19]
7 Unscheduled healthcare visits 3 Odds Ratio (M-H, Random, 95% CI) Subtotals only
7.1 Efficacy RCTs 2 531 Odds Ratio (M-H, Random, 95% CI) 0.91 [0.45, 1.85]
7.2 Cluster implementation
study
1 1213 Odds Ratio (M-H, Random, 95% CI) 0.95 [0.75, 1.21]
8 Change in lung function (trough
FEV1)
1 Mean Difference (IV, Random, 95% CI) Totals not selected
9 Adverse events 1 278 Odds Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
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Comparison 2. Remote versus face-to-face for OCS tapering
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Exacerbations requiring hospital
admission
1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
2 Asthma control (ACQ) 1 Mean Difference (IV, Random, 95% CI) Totals not selected
3 Asthma-related quality of life
(AQLQ)
1 Mean Difference (IV, Random, 95% CI) Totals not selected
4 Unscheduled healthcare visits 1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
5 Adverse events 1 Odds Ratio (M-H, Random, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 1 Exacerbations
requiring oral corticosteroids.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 1 Exacerbations requiring oral corticosteroids
Study or subgroup Remote Face-to-face Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Efficacy randomised controlled trials (RCTs)
Pinnock 2003 5/137 3/141 1.74 [ 0.41, 7.44 ]
2 Cluster implementation study
Pinnock 2007a 97/554 85/659 1.43 [ 1.04, 1.97 ]
0.2 0.5 1 2 5
Favours remote Favours face-to-face
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Analysis 1.2. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 2 Exacerbations
requiring hospital emergency department (ED) treatment.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 2 Exacerbations requiring hospital emergency department (ED) treatment
Study or subgroup Remote Face-to-face Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Efficacy RCTs
Chan 2007 4/60 2/60 65.9 % 2.07 [ 0.36, 11.76 ]
Pinnock 2003 0/137 0/141 Not estimable
Rasmussen 2005 2/85 1/168 34.1 % 4.02 [ 0.36, 45.02 ]
Subtotal (95% CI) 282 369 100.0 % 2.60 [ 0.63, 10.64 ]
Total events: 6 (Remote), 3 (Face-to-face)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.19, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 1.33 (P = 0.18)
2 Cluster implementation study
Pinnock 2007a 6/554 6/658 100.0 % 1.19 [ 0.38, 3.71 ]
Subtotal (95% CI) 554 658 100.0 % 1.19 [ 0.38, 3.71 ]
Total events: 6 (Remote), 6 (Face-to-face)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Chi2 = 0.71, df = 1 (P = 0.40), I2 =0.0%
0.01 0.1 1 10 100
Favours remote Favours face-to-face
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Analysis 1.3. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 3 Exacerbations
requiring hospital admission.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 3 Exacerbations requiring hospital admission
Study or subgroup Remote Face-to-face
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
1 Efficacy RCTs
Pinnock 2003 0/137 0/141 Not estimable
Rasmussen 2005 0/85 1/168 31.0 % 0.22 [ 0.00, 14.06 ]
Chan 2007 1/60 1/60 69.0 % 1.00 [ 0.06, 16.18 ]
Subtotal (95% CI) 282 369 100.0 % 0.63 [ 0.06, 6.32 ]
Total events: 1 (Remote), 2 (Face-to-face)
Heterogeneity: Chi2 = 0.35, df = 1 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
2 Cluster implementation study
Pinnock 2007a 11/554 6/659 100.0 % 2.18 [ 0.83, 5.69 ]
Subtotal (95% CI) 554 659 100.0 % 2.18 [ 0.83, 5.69 ]
Total events: 11 (Remote), 6 (Face-to-face)
Heterogeneity: not applicable
Test for overall effect: Z = 1.59 (P = 0.11)
Test for subgroup differences: Chi2 = 0.95, df = 1 (P = 0.33), I2 =0.0%
0.01 0.1 1 10 100
Favours remote Favours face-to-face
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Analysis 1.4. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 4 Asthma control
(Asthma Control Questionnaire (ACQ)).
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 4 Asthma control (Asthma Control Questionnaire (ACQ))
Study or subgroup Remote Face-to-face
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Efficacy RCTs
Gruffydd-Jones 2005 (1) 84 -0.18 (0.9216) 62 -0.11 (0.8269) -0.07 [ -0.35, 0.21 ]
2 Cluster implementation study
Pinnock 2007a (2) 270 1.2 (1) 266 1.33 (1.13) -0.13 [ -0.31, 0.05 ]
-0.5 -0.25 0 0.25 0.5
Favours remote Favours face-to-face
(1) change from baseline, 0 to 12 months
(2) endpoint scores at 12 months
Analysis 1.5. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 5 Serious adverse events
(including mortality).
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 5 Serious adverse events (including mortality)
Study or subgroup Remote Face-to-face Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Cluster implementation study
Pinnock 2007a (1) 12/554 8/659 1.80 [ 0.73, 4.44 ]
0.01 0.1 1 10 100
Favours remote Favours face-to-face
(1) Just mortality
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Analysis 1.6. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 6 Asthma-related quality
of life (Asthma Quality of Life Questionnaire (AQLQ).
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 6 Asthma-related quality of life (Asthma Quality of Life Questionnaire (AQLQ)
Study or subgroup Remote Face-to-face
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Efficacy RCTs
Chan 2007 (1) 60 6.1 (1.1) 60 5.8 (1.2) 25.7 % 0.30 [ -0.11, 0.71 ]
Gruffydd-Jones 2005 (2) 84 5.93 (1.64) 62 5.79 (0.9) 25.2 % 0.14 [ -0.28, 0.56 ]
Pinnock 2003 (3) 137 5.15 (1.28) 141 5.22 (1.14) 49.1 % -0.07 [ -0.36, 0.22 ]
Subtotal (95% CI) 281 263 100.0 % 0.08 [ -0.14, 0.30 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 2.23, df = 2 (P = 0.33); I2 =10%
Test for overall effect: Z = 0.70 (P = 0.48)
2 Cluster implementation study
Pinnock 2007a (4) 270 5.29 (1.21) 266 5.31 (1.24) 100.0 % -0.02 [ -0.23, 0.19 ]
Subtotal (95% CI) 270 266 100.0 % -0.02 [ -0.23, 0.19 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Chi2 = 0.41, df = 1 (P = 0.52), I2 =0.0%
-0.5 -0.25 0 0.25 0.5
Favours face-to-face Favours remote
(1) Child scale data used. Parent scale is reported narratively.
(2) Endpoint scores at 12 months
(3) Endpoint scores - trial length variable
(4) Endpoint scores at 12 months
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Analysis 1.7. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 7 Unscheduled
healthcare visits.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 7 Unscheduled healthcare visits
Study or subgroup Remote Face-to-face Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Efficacy RCTs
Pinnock 2003 (1) 27/137 34/141 82.7 % 0.77 [ 0.44, 1.37 ]
Rasmussen 2005 (2) 3/85 3/168 17.3 % 2.01 [ 0.40, 10.19 ]
Subtotal (95% CI) 222 309 100.0 % 0.91 [ 0.45, 1.85 ]
Total events: 30 (Remote), 37 (Face-to-face)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.19, df = 1 (P = 0.28); I2 =16%
Test for overall effect: Z = 0.26 (P = 0.80)
2 Cluster implementation study
Pinnock 2007a 173/554 213/659 100.0 % 0.95 [ 0.75, 1.21 ]
Subtotal (95% CI) 554 659 100.0 % 0.95 [ 0.75, 1.21 ]
Total events: 173 (Remote), 213 (Face-to-face)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.91), I2 =0.0%
0.2 0.5 1 2 5
Favours remote Favours face-to-face
(1) Not described as ’unscheduled’ - total GP visits
(2) Face-to-face GP and specialist care control groups combined
51Remote versus face-to-face check-ups for asthma (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.8. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 8 Change in lung
function (trough FEV1).
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 8 Change in lung function (trough FEV1)
Study or subgroup Remote Face-to-face
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Rasmussen 2005 (1) 85 187 (368.7818) 168 20.24 (274.8833) 166.76 [ 78.03, 255.50 ]
-200 -100 0 100 200
Favours face-to-face Favours remote
(1) Face-to-face GP and specialist care control groups combined
Analysis 1.9. Comparison 1 Remote versus face-to-face asthma reviews, Outcome 9 Adverse events.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 1 Remote versus face-to-face asthma reviews
Outcome: 9 Adverse events
Study or subgroup Remote Face-to-face Odds Ratio Weight Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Pinnock 2003 0/137 0/141 Not estimable
Total (95% CI) 137 141 Not estimable
Total events: 0 (Remote), 0 (Face-to-face)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours remote Favours face-to-face
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Analysis 2.1. Comparison 2 Remote versus face-to-face for OCS tapering, Outcome 1 Exacerbations
requiring hospital admission.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 2 Remote versus face-to-face for OCS tapering
Outcome: 1 Exacerbations requiring hospital admission
Study or subgroup Remote Face-to-face Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hashimoto 2011 6/51 5/38 0.88 [ 0.25, 3.13 ]
0.01 0.1 1 10 100
Favours remote Favours face-to-face
Analysis 2.2. Comparison 2 Remote versus face-to-face for OCS tapering, Outcome 2 Asthma control
(ACQ).
Review: Remote versus face-to-face check-ups for asthma
Comparison: 2 Remote versus face-to-face for OCS tapering
Outcome: 2 Asthma control (ACQ)
Study or subgroup Remote Face-to-face
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hashimoto 2011 51 0.26 (0.6427) 38 0.12 (0.7397) 0.14 [ -0.15, 0.43 ]
-1 -0.5 0 0.5 1
Favours remote Favours face-to-face
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Analysis 2.3. Comparison 2 Remote versus face-to-face for OCS tapering, Outcome 3 Asthma-related
quality of life (AQLQ).
Review: Remote versus face-to-face check-ups for asthma
Comparison: 2 Remote versus face-to-face for OCS tapering
Outcome: 3 Asthma-related quality of life (AQLQ)
Study or subgroup Remote Face-to-face
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Hashimoto 2011 51 -0.03 (0.7141) 38 0.14 (0.8014) -0.17 [ -0.49, 0.15 ]
-1 -0.5 0 0.5 1
Favours face-to-face Favours remote
Analysis 2.4. Comparison 2 Remote versus face-to-face for OCS tapering, Outcome 4 Unscheduled
healthcare visits.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 2 Remote versus face-to-face for OCS tapering
Outcome: 4 Unscheduled healthcare visits
Study or subgroup Remote Face-to-face Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hashimoto 2011 3/51 1/38 2.31 [ 0.23, 23.14 ]
0.01 0.1 1 10 100
Favours remote Favours face-to-face
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Analysis 2.5. Comparison 2 Remote versus face-to-face for OCS tapering, Outcome 5 Adverse events.
Review: Remote versus face-to-face check-ups for asthma
Comparison: 2 Remote versus face-to-face for OCS tapering
Outcome: 5 Adverse events
Study or subgroup Remote Face-to-face Odds Ratio Odds Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Hashimoto 2011 2/51 1/38 1.51 [ 0.13, 17.29 ]
0.01 0.1 1 10 100
Favours remote Favours face-to-face
A D D I T I O N A L T A B L E S
Table 1. Summary of study and intervention characteristics
Study ID Total N Country Duration Mean age % male % FEV1 Intervention Control
Chan 2007 120 Hawaii, USA 12 months 9.6 62.5 100.5 In-home, website-
based case manage-
ment and educa-
tion.
In-person
education and case
management.
Gruffydd-
Jones 2005
194 UK 12 months 50.2 45.4 NR 6-monthly phone
calls from trained
asthma nurses. For-
mulation of indi-
vidual AAP
6-monthly usual
face-to-face ap-
pointment with an
asthma
nurse. Symptoms,
peak flow and in-
haler technique
checked, and par-
ticipants were is-
sued with an AAP
Hashimoto
2011
95 The Nether-
lands
6 months 50.1 45.3 73.9 OCS dose adjust-
ment guided by an
internet-based di-
ary, decision sup-
port and monitor-
ing with support
from a study nurse
OCS dose adjust-
ment according to
GINA by the spe-
cialist.
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Table 1. Summary of study and intervention characteristics (Continued)
Pinnock
2003
278 UK 3 months 55.5 41.4 NR Telephone check-
up with the asthma
nurse.
Face-to-face check-
ups in the surgery
with the asthma
nurse.
Pinnock
2007a
1728 UK 12 months 42.6 44.6 NR Three invi-
tations to book ei-
ther a telephone or
face-to-face check-
up. Non-attenders
were phoned and
reviewed
opportunistically
Three in-
vitations to book a
face-to-face check-
up. Non-attenders
were not phoned
opportunistically
Rasmussen
2005
300 Denmark 6 months 29 34.5 92.0 Participants were
given an AAP, on-
line electronic diary
and peak flow me-
ter. Physicians gave
participants
instructions via e-
mail or telephone
aided by computer
decision support
The special-
ists taught the par-
ticipants how to ad-
just their medica-
tion on the basis of
a peak flow meter
and AAP
Total N: the total number of participants randomised in the study, included to groups not analysed in this Cochrane review
% FEV1: the baseline mean of the predicted normal values
Abbreviations: AAP = asthma action plan; NR = not reported; OCS = oral corticosteroids
A P P E N D I C E S
Appendix 1. Sources and search methods for the Cochrane Airways Review Group’s Specialised
Register (CAGR)
Electronic searches: core databases
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Database Search frequency
CENTRAL (the Cochrane Library) Monthly
MEDLINE (Ovid) Weekly
Embase (Ovid) Weekly
PsycINFO (Ovid) Monthly
CINAHL (EBSCO) Monthly
AMED (EBSCO) Monthly
Hand-searches: core respiratory conference abstracts
Conference Years searched
AmericanAcademyofAllergy, Asthma and Immunology (AAAAI) 2001 onwards
American Thoracic Society (ATS) 2001 onwards
Asia Pacific Society of Respirology (APSR) 2004 onwards
British Thoracic Society Winter Meeting (BTS) 2000 onwards
Chest Meeting 2003 onwards
European Respiratory Society (ERS) 1992, 1994, 2000 onwards
International PrimaryCareRespiratoryGroupCongress (IPCRG) 2002 onwards
Thoracic Society of Australia and New Zealand (TSANZ) 1999 onwards
MEDLINE search strategy used to identify trials for the CAGR
Asthma search
1. exp Asthma/
2. asthma$.mp.
3. (antiasthma$ or anti-asthma$).mp.
4. Respiratory Sounds/
5. wheez$.mp.
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6. Bronchial Spasm/
7. bronchospas$.mp.
8. (bronch$ adj3 spasm$).mp.
9. bronchoconstrict$.mp.
10. exp Bronchoconstriction/
11. (bronch$ adj3 constrict$).mp.
12. Bronchial Hyperreactivity/
13. Respiratory Hypersensitivity/
14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.
15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.
16. or/1-15
Filter to identify randomised controlled trials (RCTs)
1. exp ”clinical trial [publication type]“/
2. (randomised or randomised).ab,ti.
3. placebo.ab,ti.
4. dt.fs.
5. randomly.ab,ti.
6. trial.ab,ti.
7. groups.ab,ti.
8. or/1-7
9. Animals/
10. Humans/
11. 9 not (9 and 10)
12. 8 not 11
The MEDLINE strategy and RCT filter are adapted to identify trials in other electronic databases.
Appendix 2. Search strategy to identify relevant trials from the CAGR
#1 AST:MISC1
#2 MeSH DESCRIPTOR Asthma Explode All
#3 asthma*:ti,ab
#4 #1 or #2 or #3
#5 MeSH DESCRIPTOR Telemedicine Explode All
#6 telehealth* or tele-health*
#7 telemedicine* or tele-medicine*
#8 (internet* or computer* or web*):ti,ab,kw
#9 interactive* or telecommunication*
#10 (telephone or phone or SMS):ti,ab,kw
#11 tele-monitor* or telemonitor*
#12 telemanagement or tele-management
#13 teleconsultation or tele-consultation
#14 telecare* or tele-care*
#15 telematic*
#16 telepharmacy or tele-pharmacy
#17 telenurs* or tele-nurs*
#18 (video or email or e-mail):ti,ab,kw
#19 remote NEXT consult*
#20 wireless or bluetooth
#21 tele-homecare or telehomecare
#22 ”remote care“
#23 tele-support or telesupport
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#24 mobile NEXT health*
#25 ”computer mediated therapy“
#26 ehealth or e-health
#27 mhealth or m-health
#28 #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23
or #24 or #25 or #26 or #27
#29 #4 and #28
[Note: in search line #1, MISC1 denotes the field in which the reference has been coded for condition, in this case, asthma]
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We assessed participant and personnel blinding separately for the objective and subjective outcomes, which we had not planned in the
protocol (Kew 2015b). We were unable to conduct the subgroup analyses for age and type of technology due to an insufficient number
of included studies.
We included exacerbations that required hospital admission rather than adverse events in the ’Summary of findings’ table. We could
not include both as we had to keep to seven outcomes to adhere to guidelines, and we considered the hospital admission data to be
more important than all adverse events which tended to be reported as part of the exacerbation and resource us data in the studies.
We removed a sentence about searching manufacturer websites from the methods as it came from a template and is irrelevant to this
research question.
As discussed in the ’Unit of analysis issues’ section, we did not anticipate the inclusion of a cluster randomised controlled trial (RCT)
so we had not outlined how we would deal with Pinnock 2007a, a large two-cluster implementation study that we identified. We
included it because it met the other inclusion criteria, but we presented it separately from the other studies due to the differences in
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the study’s design and analyses. For clarity in the analyses and write-up, we referred to Pinnock 2007a as the ’cluster implementation
study’ and Chan 2007, Gruffydd-Jones 2005, Pinnock 2003 and Rasmussen 2005 as the ’efficacy RCTs’. There were only two clusters
so we included the data with participants as the unit of analysis.
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